This content is in French.
Childhood Pneumonia: Toward New Therapeutic Strategies?
15 novembre 2024
Childhood pneumonia remains a major public health concern. Despite
advancements in medical treatments and vaccination programs that have reduced
the incidence of severe cases, community-acquired pneumonia (CAP) continues to
be a leading cause of pediatric hospitalizations. In light of this, exploring
new therapeutic strategies is essential to enhance treatments and prevent
severe complications. This study investigates the efficacy of novel therapeutic
approaches for treating CAP.
Amoxicillin as a First-Line Treatment for Childhood Pneumonia?
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Donà, D., et al (2024). Treatment of mild to moderate community-acquired pneumonia in previously healthy children: an Italian intersociety consensus (SIPPS-SIP-SITIP-FIMP-SIAIP-SIMRI-FIMMG-SIMG). Italian Journal of Pediatrics, 50(1), 1-27.
View the source
